ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,890Medicare Part D Prescriptions Filled, Including Refills

Rank: 220 out of 670

$384K Total Retail Price of All Prescriptions

Rank: 285 out of 670

215 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 215 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 215 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 4,423 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LEVOTHYROXINE SODIUM 475 284 1 2
SIMVASTATIN 209 121 2 4
OMEPRAZOLE 208 128 3 5
METFORMIN HCL 192 91 4 8
FUROSEMIDE 187 115 5 6
ENALAPRIL MALEATE 178 95 6 49
TRAMADOL HCL 154 71 7 21
AMLODIPINE BESYLATE 150 93 8 7
HYDROCODONE-ACETAMINOPHEN 147 107 S3 9 1
HYDROCHLOROTHIAZIDE 145 89 10 10
METOPROLOL SUCCINATE 142 81 11 12
PRAVASTATIN SODIUM 138 60 12 19
LISINOPRIL 137 87 13 3
LOSARTAN POTASSIUM 124 105 14 26
CITALOPRAM HBR 122 57 15 20
NEXIUM 121 57 16 14
ATENOLOL 117 84 17 17
KLOR-CON M20 114 103 18 57
GABAPENTIN 106 33 19 11
CRESTOR 86 54 20 18
RANITIDINE HCL 80 51 21 25
FLUOXETINE HCL 80 50 21 55
METOPROLOL TARTRATE 75 53 23 9
LANTUS SOLOSTAR 73 46 24 98
SYNTHROID 70 50 25 47
CEFUROXIME 69 31 26 121
LOSARTAN-HYDROCHLOROTHIAZIDE 69 33 26 73
POTASSIUM CHLORIDE 68 34 28 16
ATORVASTATIN CALCIUM 65 56 29 15
KLOR-CON M10 65 41 29 112
WARFARIN SODIUM 61 43 31 13
CYMBALTA 60 0 32 36
PRISTIQ ER 60 0 32 297
ZOLPIDEM TARTRATE 54 38 34 23
FLUCONAZOLE 51 11 35 140
VENLAFAXINE HCL ER 51 22 35 97
ISOSORBIDE MONONITRATE ER 50 35 37 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.